Eli Lilly acquires SiteOne Therapeutics to advance treatment for chronic pain
Global biopharma Eli Lilly will acquire SiteOne Therapeutics, a biotech dedicated to the...
Read More
Tag: Chronic pain
NICE publishes new guidance on chronic pain management
Guidelines recommend exercise programmes and psychological therapies rather than commonly used drugs
Read More
NICE updates guidance on chronic pain treatments
Draft guidance says some commonly used drug treatments should be avoided
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
